Sign In

Glenna Crooks, Ph.D.

Global Strategic Consultant in health, longevity, and policy. Known for transformational solutions to complex problems. Zen artist. Soup Angel. #TheNetworkSage

Glenna Crooks, Ph.D. is a highly experienced healthcare policy strategist and innovator with a diverse background in public health, policy, and business. She is currently associated with Ingeni Health as a Health and Longevity Strategist.14

Professional Background

Dr. Crooks is the founder and CEO of Strategic Health Policy International, Inc., a global consulting firm she established in 1994. The firm specializes in organizing chaos and solving complex healthcare problems for clients across various sectors and geographies.1

Her career highlights include:

  • Global Vice President of Vaccine Business at Merck from 1992 to 1994, where she grew sales from $400 million to over $1 billion in just over two years.1
  • Member of the Firm at The Pagonis and Donnelly Group, where she led the healthcare practice and advised on strategy and implementation of legislation, regulation, and various healthcare issues.1
  • Board Member and Audit Committee Member for American Biogenetic Sciences, Inc., a startup biotechnology company focused on rare diseases.1

Expertise and Contributions

Dr. Crooks is known for her ability to develop innovative solutions in healthcare, policy, and advocacy. Some of her notable contributions include:

  • Developing legislation to increase pharmaceutical studies in children
  • Creating national plans to eliminate viral hepatitis and improve care for veterans with rare diseases
  • Expanding the influenza vaccine market by changing age recommendations for universal use1

Education and Recognition

With an interdisciplinary Ph.D. in health sciences, social sciences, law, and journalism, Dr. Crooks has been called a "one-woman think tank" for her innovative work in education and healthcare.5

Current Role

As a Health and Longevity Strategist at Ingeni Health, Dr. Crooks is involved in the development and implementation of state-of-the-art AI technology designed to empower seniors and enhance their quality of life.34

Dr. Crooks maintains an active presence on LinkedIn under the username glennacrooksphd, where she shares insights on healthcare, policy, and career development.2

Highlights

Aug 6 · linkedin

This season would have been a bad time to be ill in ancient Greece. Why?

Hippocrates advised his students against treating patients with medicines when the “dog star was high in the sky.”

The star he referenced was Sirius, part of the constellation Canis Major. It is 25 times more luminous than the sun and only 8.6 light years away, making it the brightest star in the night sky during summer.

Thus, people believed the combination of the day’s sun and night’s Sirus star caused the intense heat of summer. It’s where we get the expression “the dog days of summer.”

Why not treat patients with medicines at that time? What did Hippocrates observe that led to that advice?

I called my guru on such matters, Pharmacy Professor Robert (Bob) Freeman, PhD.  We’ve been friends for over 25 years, dating back to his days at AstraZeneca when he worked on health economics and policy matters.

Bob knew.

Most medicines, he told me, lose their efficacy when they’re stored in temperatures of 80-85 degrees and higher. Hippocrates observed in people what today’s analytical chemists can demonstrate in labs.

We spoke about this last month, which is when I also learned that he was looking forward to returning to the School of Pharmacy at the University of Maryland Eastern Shore campus. Our current interests were intersecting once again and it appeared we’d have the chance to work together again soon. I was delighted to know that.

I’m sharing this bit of Hippocrates trivia because it gives me an opportunity to pay tribute to Bob, who was always there as wise counsel and good friend. I was devastated to learn of his passing this weekend. I’m not the only one who will miss him.

Bob was beloved by his students; they will miss his mentorship. He was appreciated by his colleagues; they will miss his careful scholarship, wisdom, and droll, curmudgeonly sense of humor. His friends will miss his readiness to help.

His family will miss him most of all, of course, and we’ll miss hearing about them. Bob was generous with all of us in sharing about them. We’ve heard the stories and seen the photos of their milestones and merit. He loved them, he was proud of them and he allowed us to share his joy.

David Brooks wrote recently about resume virtues and eulogy virtues.

Bob had both.

Jul 23 · linkedin

Can AI become a surrogate decision-maker to speak for incapacitated patients at the end of their lives? Maybe.

Should it? That will surely be up for debate since yesterday's JAMA Internal Medicine publication.

In the coming weeks, colleagues and I will discuss what we believe is missing from the current AI 'hype cycle' in healthcare.

It's this. If those who use AI are going to wade into the healing streams that began thousands of years ago and pledged to do only good, they, too, should ascribe to a healer's oath, much like those today who take the oaths of Hippocrates.

We've drafted one.

If you're interested in learning more, leave a comment, and we'll ensure you receive it "hot off the press."

Related Questions

What are some of the most significant projects Glenna Crooks has led at Ingeni Health?
How has Glenna Crooks' interdisciplinary Ph.D. influenced her approach to health policy?
What are the key achievements of Strategic Health Policy International, Inc. under Glenna Crooks' leadership?
How does Glenna Crooks' work at Ingeni Health contribute to the field of health and longevity?
Can you provide examples of Glenna Crooks' impact on global health initiatives?
Glenna Crooks, Ph.D.
Glenna Crooks, Ph.D., photo 1
Glenna Crooks, Ph.D., photo 2
Add to my network

Location

United States